These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2906214)

  • 21. Low levels of somatostatin in human CSF mark depressive episodes.
    Agren H; Lundqvist G
    Psychoneuroendocrinology; 1984; 9(3):233-48. PubMed ID: 6149588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CSF somatostatin-like immunoreactivity in dementia.
    Beal MF; Growdon JH; Mazurek MF; Martin JB
    Neurology; 1986 Feb; 36(2):294-7. PubMed ID: 2868429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevation of CSF somatostatin concentrations in mania.
    Sharma RP; Bissette G; Janicak PG; Davis JM; Nemeroff CB
    Am J Psychiatry; 1995 Dec; 152(12):1807-9. PubMed ID: 8526251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CSF somatostatin in affective illness.
    Rubinow DR; Gold PW; Post RM; Ballenger JC; Cowdry R; Bollinger J; Reichlin S
    Arch Gen Psychiatry; 1983 Apr; 40(4):409-12. PubMed ID: 6132592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatostatin-like immunoreactivity in the cerebrospinal fluid of neurological patients.
    Kohler J; Schröter E; Cramer H
    Arch Psychiatr Nervenkr (1970); 1982; 231(6):503-8. PubMed ID: 6127989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatostatin and cognitive functions in Alzheimer's disease--the relationship of cerebrospinal fluid somatostatin increase with clinical response to tetrahydroaminoacridine.
    Alhainen K; Sirviö J; Helkala EL; Reinikainen K; Riekkinen P
    Neurosci Lett; 1991 Sep; 130(1):46-8. PubMed ID: 1684233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatostatin in human cerebrospinal fluid.
    Patel Y; Rao K; Reichlin S
    N Engl J Med; 1977 Mar; 296(10):529-33. PubMed ID: 836537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.
    Molchan SE; Lawlor BA; Hill JL; Martinez RA; Davis CL; Mellow AM; Rubinow DR; Sunderland T
    Biol Psychiatry; 1991 Jun; 29(11):1110-8. PubMed ID: 1714776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropeptide Y (NPY) and the central nervous system: distribution effects and possible relationship to neurological and psychiatric disorders.
    Wahlestedt C; Ekman R; Widerlöv E
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):31-54. PubMed ID: 2664885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment.
    Heuser I; Bissette G; Dettling M; Schweiger U; Gotthardt U; Schmider J; Lammers CH; Nemeroff CB; Holsboer F
    Depress Anxiety; 1998; 8(2):71-9. PubMed ID: 9784981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion.
    Kling MA; Rubinow DR; Doran AR; Roy A; Davis CL; Calabrese JR; Nieman LK; Post RM; Chrousos GP; Gold PW
    Neuroendocrinology; 1993 Jan; 57(1):79-88. PubMed ID: 8097579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatostatin and neuropeptide Y in cerebrospinal fluid: correlations with severity of disease and clinical signs in Alzheimer's disease and frontotemporal dementia.
    Minthon L; Edvinsson L; Gustafson L
    Dement Geriatr Cogn Disord; 1997; 8(4):232-9. PubMed ID: 9213068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer's disease and neurological disorders.
    Cacabelos R; Barquero M; García P; Alvarez XA; Varela de Seijas E
    Methods Find Exp Clin Pharmacol; 1991 Sep; 13(7):455-8. PubMed ID: 1784142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid somatostatin correlates with spectral EEG variables and with parietotemporal cognitive dysfunction in Alzheimer patients.
    Soininen H; Riekkinen PJ; Partanen J; Helkala EL; Laulumaa V; Jolkkonen J; Reinikainen K
    Neurosci Lett; 1988 Feb; 85(1):131-6. PubMed ID: 2896317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid vasopressin, oxytocin, somatostatin, and beta-endorphin in Alzheimer's disease.
    Raskind MA; Peskind ER; Lampe TH; Risse SC; Taborsky GJ; Dorsa D
    Arch Gen Psychiatry; 1986 Apr; 43(4):382-8. PubMed ID: 2869744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postmortem and cerebrospinal fluid studies of corticotropin-releasing factor in humans.
    Hartline KM; Owens MJ; Nemeroff CB
    Ann N Y Acad Sci; 1996 Mar; 780():96-105. PubMed ID: 8602742
    [No Abstract]   [Full Text] [Related]  

  • 37. The origin of cerebrospinal fluid somatostatin: hypothalamic or disperse central nervous system secretion?
    Sørensen KV; Christensen SE; Hansen AP; Ingerslev J; Pedersen E; Orskov H
    Neuroendocrinology; 1981 Jun; 32(6):335-8. PubMed ID: 6165919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatostatin cerebrospinal fluid levels in dementia.
    Molins A; Catalán R; Sahuquillo J; Castellanos JM; Codina A; Galard R
    J Neurol; 1991 Jun; 238(3):168-70. PubMed ID: 1678420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced lumbar CSF somatostatin levels in Alzheimer's disease.
    Wood PL; Etienne P; Lal S; Gauthier S; Cajal S; Nair NP
    Life Sci; 1982 Nov; 31(19):2073-9. PubMed ID: 6184590
    [No Abstract]   [Full Text] [Related]  

  • 40. Somatostatin in multiple sclerosis.
    Sørensen KV
    Acta Neurol Scand; 1987 Mar; 75(3):161-7. PubMed ID: 2883805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.